BHVN (BHVN) Stock Price & Analysis
BHVN (BHVN) rose 0.00% to USD 14.32 as of July 26, 2026 at 13:10 UTC, according to Nexqual real-time market data.
BHVN last closed at USD 14.32; the session ranged USD 13.88–14.98 on volume of 1,461,041 shares. Market capitalization is —, with a 52-week range of USD 7.48–18.57 (NYQ). Source: Nexqual, July 26, 2026 at 13:10 UTC.
Key Statistics (as of July 26, 2026 at 13:10 UTC)
| Price | USD 14.32 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 14.32 |
| Open | USD 14.32 |
| Day Range | USD 13.88 – 14.98 |
| 52-Week Range | USD 7.48 – 18.57 |
| Volume | 1,461,041 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BHVN)
Nexqual's technical model rates BHVN "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 26, 2026 at 13:10 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.05 (neutral) |
| vs SMA50 | Above (USD 12.86) |
| MACD | 0.4 (positive) |
From BHVN's Latest SEC 10-K Filing (filed 2026-03-02)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | USD 84.02 | ▲ 1.65% |
| DNLI | Denali Therapeutics Inc. | USD 23.11 | ▼ 2.24% |
| ARVN | Arvinas, Inc. | USD 8.03 | ▼ 2.78% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 26.9 | ▼ 2.69% |
| MDGL | Madrigal Pharmaceuticals, Inc. | USD 544.51 | ▲ 1.28% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 13:10 UTC. This page is informational and not investment advice.